Risk Factors for Graft-Versus-Host Disease After Transplantation of Hematopoietic Stem Cells from Unrelated Donors in the China Marrow Donor Program-Reference-Cited by-同舟云学术

Risk Factors for Graft-Versus-Host Disease After Transplantation of Hematopoietic Stem Cells from Unrelated Donors in the China Marrow Donor Program

Published:2017-06-27 Issue: Volume:22 Page:384-401
ISSN:2329-0358
Container-title:Annals of Transplantation
language:en
Short-container-title:Ann Transplant

Author:

Yang Fan¹,Lu Daopei²,Hu Yu³,Huang Xiaojun⁴,Huang He⁵,Chen Jing⁶,Wu Depei⁷,Wang Jianmin⁸,Wang Chun⁹,Han Mingzhe¹⁰,Chen Hu¹¹

Affiliation:

1. Department of Hematopoietic Stem Cell Transplantation, Affiliated Hospital to Academy of Military Medical Sciences, Beijing, China (mainland)

2. Hebei Yanda Ludaopei Hospital, Langfang, Hebei, China (mainland)

3. Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China (mainland)

4. Peking University People’s Hospital, Beijing, China (mainland)

5. The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China (mainland)

6. Shanghai Children’s Medical Center, Shanghai, China (mainland)

7. The First Affiliated Hospital of Soochow University, Suzhou, Zhejiang, China (mainland)

8. Changhai Hospital of Shanghai, Shanghai, China (mainland)

9. ShangHai General Hospital, Shanghai, China (mainland)

10. Institute of Hematology and Hospital of Blood Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China (mainland)

11. Department of Hematopoietic Stem Cell Transplantation, Affiliated Hospital to Academy of Military Medical Sciences, , China (mainland)

Publisher

International Scientific Information, Inc.

Subject

Transplantation,General Medicine

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cutaneous graft-versus-host disease;The Rose and Mackay Textbook of Autoimmune Diseases;2024

2. Understanding and treatment of cutaneous graft-versus-host-disease;Bone Marrow Transplantation;2023-09-20

3. Efficacy and safety of CD19 CAR-T cell therapy for acute lymphoblastic leukemia patients relapsed after allogeneic hematopoietic stem cell transplantation;International Journal of Hematology;2022-06-23

4. Adolescent and young adult (AYA) versus pediatric patients with acute leukemia have a significantly increased risk of acute GVHD following unrelated donor (URD) stem cell transplantation (SCT): the Children’s Oncology Group experience;Bone Marrow Transplantation;2022-01-06

5. iNKT cells coordinate immune pathways to enable engraftment in nonconditioned hosts;Life Science Alliance;2021-06-10